DYNLT1 and breast cancer: We found that BC patients in the DYNLT1 high group had higher levels of DDR mutational ratio (Figure 6C), TILs regional fraction (Figure 6D), and lower TGF-beta response (Figure 6E) compared to those in the DYNLT1 low group.